Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-22

Clinical Trial Update: High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza [Phase 2]

View source ↗

Summary

This Phase 2 trial compared high-dose versus standard-dose oseltamivir for treating severe influenza and avian influenza, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamiflu (oseltamivir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza, Avian Influenza | Phase 2 | Status: COMPLETED | Results posted: 2014-05-22